Physician profile
Robert E Schwartz
NPI 1245223569
$8,009.53
in general payments reported to CMS, 2019-2025
26 companies · $879 in 2025
The $879 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,745 · 2020: $142 · 2021: $1,662 · 2022: $483 · 2023: $257 · 2024: $2,842 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,475 · Travel and Lodging: $1,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,475.08 |
| Travel and Lodging | $1,503.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $5,085.06 | 2019-2025 | Persona, Avenir, Taperloc |
| Stryker Corporation | $1,908.63 | 2019-2025 | Aequalis Perform Reversed, Mako, Hoffmann |
| Radius Health, INC. | $125.75 | 2019-2024 | Tymlos |
| Pacira Therapeutics, INC. | $101.50 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $89.48 | 2025 | |
| Restor3d, INC. | $78.51 | 2024 | |
| Djo, LLC | $73.27 | 2019 | |
| Bioventus LLC | $70.17 | 2019-2025 | Durolane |
| Conformis, INC. | $65.70 | 2021 | |
| Depuy Synthes Sales INC. | $61.50 | 2019-2022 | |
| Orthalign INC | $58.60 | 2023 | Orthalign Plus |
| Ethicon US, LLC | $38.83 | 2019 | |
| Heron Therapeutics, INC. | $30.00 | 2022 | |
| Kyowa Kirin, INC. | $27.02 | 2024 | Crysvita |
| Hikma Pharmaceuticals USA | $21.00 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $18.56 | 2021 | |
| Ferring Pharmaceuticals INC. | $18.49 | 2020 | |
| Davol INC. | $17.98 | 2024 | Arista Ah Flexitip |
| Kci USA, INC. | $16.67 | 2023 | Prevena, V.A.C. Veraflo |
| Vericel Corporation | $16.45 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.29 | 2019 | |
| Solventum Corporation | $15.96 | 2025 | Prevena |
| Smith+Nephew, INC. | $15.13 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.53 | 2023 | Seglentis |
| Amgen INC. | $13.96 | 2019 | |
| Fx Shoulder Solutions, INC | $10.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.